Rebound of pediatric invasive pneumococcal disease in Portugal after the COVID-19 pandemic was not associated with significant serotype changes
Open Access
- 6 August 2024
- journal article
- research article
- Published by Elsevier in Journal of Infection
- Vol. 89 (4) , 106242
Abstract
No abstract availableKeywords
Funding Information
- Pfizer
- Fundação para a Ciência e a Tecnologia (PTDC/DTP-EPI/1555/2014)
This publication has 24 references indexed in Scilit:
- A multicenter study on the epidemiology of complicated parapneumonic effusion in the era of currently available pneumococcal conjugate vaccinesVaccine, 2023
- Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS ConsortiumThe Lancet Digital Health, 2023
- Impact of PCV10 on pediatric pneumococcal disease burden in Brazil: time for new recommendations?Jornal de Pediatria, 2022
- Emergence of a multidrug-resistant and virulent Streptococcus pneumoniae lineage mediates serotype replacement after PCV13: an international whole-genome sequencing studyThe Lancet Microbe, 2022
- Association of Nonpharmaceutical Interventions During the COVID-19 Pandemic With Invasive Pneumococcal Disease, Pneumococcal Carriage, and Respiratory Viral Infections Among Children in FranceJAMA Network Open, 2022
- Decline in Pneumococcal Disease in Young Children During the Coronavirus Disease 2019 (COVID-19) Pandemic in Israel Associated With Suppression of Seasonal Respiratory Viruses, Despite Persistent Pneumococcal Carriage: A Prospective Cohort StudyClinical Infectious Diseases, 2021
- Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance dataThe Lancet Digital Health, 2021
- Characteristics of Invasive Pneumococcal Disease Caused by Emerging Serotypes After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in England: A Prospective Observational Cohort Study, 2014–2018Clinical Infectious Diseases, 2020
- Increase in Streptococcus pneumoniae serotype 3 associated parapneumonic pleural effusion/empyema after the introduction of PCV13 in GermanyVaccine, 2020
- Dominance of vaccine serotypes in pediatric invasive pneumococcal infections in Portugal (2012–2015)Scientific Reports, 2019